Author

Guzman Alonso

Institution: Vall d'Hebron Institute of Oncology

Observed institution: Vall d'Hebron Institute of Oncology

OpenAlex ID: A5137168528

Efficacy and safety of pralsetinib in advanced or metastatic RET -altered thyroid cancer (TC): Final analysis of the phase 1/2 ARROW study.

2026 · Vivek Subbiah, Aaron Scott Mansfield, et al. · Journal of Clinical Oncology · 1

Works count: 1

Citation count: 1

H-index: 1

I10-index: